1	to	_	To	_	TO	0	_	_	_	_	_	_	_	O
2	identify	_	identify	_	VB	0	_	_	_	_	_	_	_	O
3	further	_	further	_	JJ	0	_	_	_	_	_	further.a	Increment	O
4	susceptibility	_	UNK	_	NN	0	_	_	_	_	_	_	_	B-Class
5	alleles	_	UNK	_	NNS	0	_	_	_	_	_	_	_	I-Class
6	,	_	,	_	,	0	_	_	_	_	_	_	_	O
7	we	_	we	_	PRP	0	_	_	_	_	_	_	_	O
8	conducted	_	conduct	_	VBD	0	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	0	_	_	_	_	_	_	_	O
10	two-stage	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
11	genome-wide	_	UNK	_	JJ	0	_	_	_	_	_	_	_	O
12	association	_	association	_	NN	0	_	_	_	_	_	_	_	O
13	study	_	study	_	NN	0	_	_	_	_	_	_	_	O
14	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
16	breast	_	breast	_	NN	0	_	_	_	_	_	_	_	O
17	cancer	_	cancer	_	NN	0	_	_	_	_	_	_	_	O
18	cases	_	case	_	NNS	0	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
21	controls	_	control	_	NNS	0	_	_	_	_	_	_	_	O
22	,	_	,	_	,	0	_	_	_	_	_	_	_	O
23	followed	_	follow	_	VBD	0	_	_	_	_	_	_	_	O
24	by	_	by	_	IN	0	_	_	_	_	_	_	_	O
25	a	_	a	_	DT	0	_	_	_	_	_	_	_	O
26	third	_	third	_	JJ	0	_	_	_	_	_	_	_	O
27	stage	_	stage	_	NN	0	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
29	which	_	which	_	WDT	0	_	_	_	_	_	_	_	O
30	30	_	30	_	CD	0	_	_	_	_	_	_	_	O
31	single	_	single	_	JJ	0	_	_	_	_	_	_	_	O
32	nucleotide	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
33	polymorphisms	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O
34	(	_	(	_	:	0	_	_	_	_	_	_	_	O
35	snps	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
36	)	_	)	_	:	0	_	_	_	_	_	_	_	O
37	were	_	be	_	VBD	0	_	_	_	_	_	_	_	O
38	tested	_	test	_	VBN	0	_	_	_	_	_	_	_	O
39	for	_	for	_	IN	0	_	_	_	_	_	_	_	O
40	confirmation	_	confirmation	_	NN	0	_	_	_	_	_	_	_	O
41	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
42	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
43	cases	_	case	_	NNS	0	_	_	_	_	_	_	_	O
44	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
45	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
46	controls	_	control	_	NNS	0	_	_	_	_	_	_	_	O
47	from	_	from	_	IN	0	_	_	_	_	_	_	_	O
48	s22	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
49	studies	_	study	_	NNS	0	_	_	_	_	_	_	_	O
50	.	_	.	_	.	0	_	_	_	_	_	_	_	O

1	to	_	To	_	TO	0	_	_	_	_	_	_	_	O
2	identify	_	identify	_	VB	0	_	_	_	_	_	_	_	O
3	further	_	further	_	JJ	0	_	_	_	_	_	_	_	O
4	susceptibility	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
5	alleles	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O
6	,	_	,	_	,	0	_	_	_	_	_	_	_	O
7	we	_	we	_	PRP	0	_	_	_	_	_	_	_	S-Agent
8	conducted	_	conduct	_	VBD	0	_	_	_	_	_	conduct.v	Intentionally_act	O
9	a	_	a	_	DT	0	_	_	_	_	_	_	_	B-Act
10	two-stage	_	UNK	_	NN	0	_	_	_	_	_	_	_	I-Act
11	genome-wide	_	UNK	_	JJ	0	_	_	_	_	_	_	_	I-Act
12	association	_	association	_	NN	0	_	_	_	_	_	_	_	I-Act
13	study	_	study	_	NN	0	_	_	_	_	_	_	_	I-Act
14	in	_	in	_	IN	0	_	_	_	_	_	_	_	I-Act
15	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	I-Act
16	breast	_	breast	_	NN	0	_	_	_	_	_	_	_	I-Act
17	cancer	_	cancer	_	NN	0	_	_	_	_	_	_	_	I-Act
18	cases	_	case	_	NNS	0	_	_	_	_	_	_	_	I-Act
19	and	_	and	_	CC	0	_	_	_	_	_	_	_	I-Act
20	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	I-Act
21	controls	_	control	_	NNS	0	_	_	_	_	_	_	_	I-Act
22	,	_	,	_	,	0	_	_	_	_	_	_	_	O
23	followed	_	follow	_	VBD	0	_	_	_	_	_	_	_	O
24	by	_	by	_	IN	0	_	_	_	_	_	_	_	O
25	a	_	a	_	DT	0	_	_	_	_	_	_	_	O
26	third	_	third	_	JJ	0	_	_	_	_	_	_	_	O
27	stage	_	stage	_	NN	0	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
29	which	_	which	_	WDT	0	_	_	_	_	_	_	_	O
30	30	_	30	_	CD	0	_	_	_	_	_	_	_	O
31	single	_	single	_	JJ	0	_	_	_	_	_	_	_	O
32	nucleotide	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
33	polymorphisms	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O
34	(	_	(	_	:	0	_	_	_	_	_	_	_	O
35	snps	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
36	)	_	)	_	:	0	_	_	_	_	_	_	_	O
37	were	_	be	_	VBD	0	_	_	_	_	_	_	_	O
38	tested	_	test	_	VBN	0	_	_	_	_	_	_	_	O
39	for	_	for	_	IN	0	_	_	_	_	_	_	_	O
40	confirmation	_	confirmation	_	NN	0	_	_	_	_	_	_	_	O
41	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
42	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
43	cases	_	case	_	NNS	0	_	_	_	_	_	_	_	O
44	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
45	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
46	controls	_	control	_	NNS	0	_	_	_	_	_	_	_	O
47	from	_	from	_	IN	0	_	_	_	_	_	_	_	O
48	s22	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
49	studies	_	study	_	NNS	0	_	_	_	_	_	_	_	O
50	.	_	.	_	.	0	_	_	_	_	_	_	_	O

1	to	_	To	_	TO	0	_	_	_	_	_	_	_	O
2	identify	_	identify	_	VB	0	_	_	_	_	_	_	_	O
3	further	_	further	_	JJ	0	_	_	_	_	_	_	_	O
4	susceptibility	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
5	alleles	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O
6	,	_	,	_	,	0	_	_	_	_	_	_	_	O
7	we	_	we	_	PRP	0	_	_	_	_	_	_	_	O
8	conducted	_	conduct	_	VBD	0	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	0	_	_	_	_	_	_	_	O
10	two-stage	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
11	genome-wide	_	UNK	_	JJ	0	_	_	_	_	_	_	_	O
12	association	_	association	_	NN	0	_	_	_	_	_	_	_	O
13	study	_	study	_	NN	0	_	_	_	_	_	study.n	Scrutiny	O
14	in	_	in	_	IN	0	_	_	_	_	_	_	_	B-Ground
15	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	I-Ground
16	breast	_	breast	_	NN	0	_	_	_	_	_	_	_	I-Ground
17	cancer	_	cancer	_	NN	0	_	_	_	_	_	_	_	I-Ground
18	cases	_	case	_	NNS	0	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
21	controls	_	control	_	NNS	0	_	_	_	_	_	_	_	O
22	,	_	,	_	,	0	_	_	_	_	_	_	_	O
23	followed	_	follow	_	VBD	0	_	_	_	_	_	_	_	O
24	by	_	by	_	IN	0	_	_	_	_	_	_	_	O
25	a	_	a	_	DT	0	_	_	_	_	_	_	_	O
26	third	_	third	_	JJ	0	_	_	_	_	_	_	_	O
27	stage	_	stage	_	NN	0	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
29	which	_	which	_	WDT	0	_	_	_	_	_	_	_	O
30	30	_	30	_	CD	0	_	_	_	_	_	_	_	O
31	single	_	single	_	JJ	0	_	_	_	_	_	_	_	O
32	nucleotide	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
33	polymorphisms	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O
34	(	_	(	_	:	0	_	_	_	_	_	_	_	O
35	snps	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
36	)	_	)	_	:	0	_	_	_	_	_	_	_	O
37	were	_	be	_	VBD	0	_	_	_	_	_	_	_	O
38	tested	_	test	_	VBN	0	_	_	_	_	_	_	_	O
39	for	_	for	_	IN	0	_	_	_	_	_	_	_	O
40	confirmation	_	confirmation	_	NN	0	_	_	_	_	_	_	_	O
41	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
42	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
43	cases	_	case	_	NNS	0	_	_	_	_	_	_	_	O
44	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
45	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
46	controls	_	control	_	NNS	0	_	_	_	_	_	_	_	O
47	from	_	from	_	IN	0	_	_	_	_	_	_	_	O
48	s22	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
49	studies	_	study	_	NNS	0	_	_	_	_	_	_	_	O
50	.	_	.	_	.	0	_	_	_	_	_	_	_	O

1	to	_	To	_	TO	0	_	_	_	_	_	_	_	O
2	identify	_	identify	_	VB	0	_	_	_	_	_	_	_	O
3	further	_	further	_	JJ	0	_	_	_	_	_	_	_	O
4	susceptibility	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
5	alleles	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O
6	,	_	,	_	,	0	_	_	_	_	_	_	_	O
7	we	_	we	_	PRP	0	_	_	_	_	_	_	_	O
8	conducted	_	conduct	_	VBD	0	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	0	_	_	_	_	_	_	_	O
10	two-stage	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
11	genome-wide	_	UNK	_	JJ	0	_	_	_	_	_	_	_	O
12	association	_	association	_	NN	0	_	_	_	_	_	_	_	O
13	study	_	study	_	NN	0	_	_	_	_	_	_	_	O
14	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	S-Descriptor
16	breast	_	breast	_	NN	0	_	_	_	_	_	breast.n	Body_parts	S-Body_part
17	cancer	_	cancer	_	NN	0	_	_	_	_	_	_	_	O
18	cases	_	case	_	NNS	0	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
21	controls	_	control	_	NNS	0	_	_	_	_	_	_	_	O
22	,	_	,	_	,	0	_	_	_	_	_	_	_	O
23	followed	_	follow	_	VBD	0	_	_	_	_	_	_	_	O
24	by	_	by	_	IN	0	_	_	_	_	_	_	_	O
25	a	_	a	_	DT	0	_	_	_	_	_	_	_	O
26	third	_	third	_	JJ	0	_	_	_	_	_	_	_	O
27	stage	_	stage	_	NN	0	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
29	which	_	which	_	WDT	0	_	_	_	_	_	_	_	O
30	30	_	30	_	CD	0	_	_	_	_	_	_	_	O
31	single	_	single	_	JJ	0	_	_	_	_	_	_	_	O
32	nucleotide	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
33	polymorphisms	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O
34	(	_	(	_	:	0	_	_	_	_	_	_	_	O
35	snps	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
36	)	_	)	_	:	0	_	_	_	_	_	_	_	O
37	were	_	be	_	VBD	0	_	_	_	_	_	_	_	O
38	tested	_	test	_	VBN	0	_	_	_	_	_	_	_	O
39	for	_	for	_	IN	0	_	_	_	_	_	_	_	O
40	confirmation	_	confirmation	_	NN	0	_	_	_	_	_	_	_	O
41	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
42	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
43	cases	_	case	_	NNS	0	_	_	_	_	_	_	_	O
44	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
45	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
46	controls	_	control	_	NNS	0	_	_	_	_	_	_	_	O
47	from	_	from	_	IN	0	_	_	_	_	_	_	_	O
48	s22	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
49	studies	_	study	_	NNS	0	_	_	_	_	_	_	_	O
50	.	_	.	_	.	0	_	_	_	_	_	_	_	O

1	to	_	To	_	TO	0	_	_	_	_	_	_	_	O
2	identify	_	identify	_	VB	0	_	_	_	_	_	_	_	O
3	further	_	further	_	JJ	0	_	_	_	_	_	_	_	O
4	susceptibility	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
5	alleles	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O
6	,	_	,	_	,	0	_	_	_	_	_	_	_	O
7	we	_	we	_	PRP	0	_	_	_	_	_	_	_	O
8	conducted	_	conduct	_	VBD	0	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	0	_	_	_	_	_	_	_	B-Type
10	two-stage	_	UNK	_	NN	0	_	_	_	_	_	_	_	I-Type
11	genome-wide	_	UNK	_	JJ	0	_	_	_	_	_	_	_	I-Type
12	association	_	association	_	NN	0	_	_	_	_	_	_	_	I-Type
13	study	_	study	_	NN	0	_	_	_	_	_	_	_	I-Type
14	in	_	in	_	IN	0	_	_	_	_	_	_	_	I-Type
15	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	I-Type
16	breast	_	breast	_	NN	0	_	_	_	_	_	_	_	I-Type
17	cancer	_	cancer	_	NN	0	_	_	_	_	_	_	_	I-Type
18	cases	_	case	_	NNS	0	_	_	_	_	_	case.n	Instance	S-Instance
19	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
21	controls	_	control	_	NNS	0	_	_	_	_	_	_	_	O
22	,	_	,	_	,	0	_	_	_	_	_	_	_	O
23	followed	_	follow	_	VBD	0	_	_	_	_	_	_	_	O
24	by	_	by	_	IN	0	_	_	_	_	_	_	_	O
25	a	_	a	_	DT	0	_	_	_	_	_	_	_	O
26	third	_	third	_	JJ	0	_	_	_	_	_	_	_	O
27	stage	_	stage	_	NN	0	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
29	which	_	which	_	WDT	0	_	_	_	_	_	_	_	O
30	30	_	30	_	CD	0	_	_	_	_	_	_	_	O
31	single	_	single	_	JJ	0	_	_	_	_	_	_	_	O
32	nucleotide	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
33	polymorphisms	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O
34	(	_	(	_	:	0	_	_	_	_	_	_	_	O
35	snps	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
36	)	_	)	_	:	0	_	_	_	_	_	_	_	O
37	were	_	be	_	VBD	0	_	_	_	_	_	_	_	O
38	tested	_	test	_	VBN	0	_	_	_	_	_	_	_	O
39	for	_	for	_	IN	0	_	_	_	_	_	_	_	O
40	confirmation	_	confirmation	_	NN	0	_	_	_	_	_	_	_	O
41	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
42	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
43	cases	_	case	_	NNS	0	_	_	_	_	_	_	_	O
44	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
45	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
46	controls	_	control	_	NNS	0	_	_	_	_	_	_	_	O
47	from	_	from	_	IN	0	_	_	_	_	_	_	_	O
48	s22	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
49	studies	_	study	_	NNS	0	_	_	_	_	_	_	_	O
50	.	_	.	_	.	0	_	_	_	_	_	_	_	O

1	to	_	To	_	TO	0	_	_	_	_	_	_	_	O
2	identify	_	identify	_	VB	0	_	_	_	_	_	_	_	O
3	further	_	further	_	JJ	0	_	_	_	_	_	_	_	O
4	susceptibility	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
5	alleles	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O
6	,	_	,	_	,	0	_	_	_	_	_	_	_	O
7	we	_	we	_	PRP	0	_	_	_	_	_	_	_	O
8	conducted	_	conduct	_	VBD	0	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	0	_	_	_	_	_	_	_	B-Focal_occasion
10	two-stage	_	UNK	_	NN	0	_	_	_	_	_	_	_	I-Focal_occasion
11	genome-wide	_	UNK	_	JJ	0	_	_	_	_	_	_	_	I-Focal_occasion
12	association	_	association	_	NN	0	_	_	_	_	_	_	_	I-Focal_occasion
13	study	_	study	_	NN	0	_	_	_	_	_	_	_	I-Focal_occasion
14	in	_	in	_	IN	0	_	_	_	_	_	_	_	I-Focal_occasion
15	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	I-Focal_occasion
16	breast	_	breast	_	NN	0	_	_	_	_	_	_	_	I-Focal_occasion
17	cancer	_	cancer	_	NN	0	_	_	_	_	_	_	_	I-Focal_occasion
18	cases	_	case	_	NNS	0	_	_	_	_	_	_	_	I-Focal_occasion
19	and	_	and	_	CC	0	_	_	_	_	_	_	_	I-Focal_occasion
20	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	I-Focal_occasion
21	controls	_	control	_	NNS	0	_	_	_	_	_	_	_	I-Focal_occasion
22	,	_	,	_	,	0	_	_	_	_	_	_	_	O
23	followed	_	follow	_	VBD	0	_	_	_	_	_	follow.v	Relative_time	O
24	by	_	by	_	IN	0	_	_	_	_	_	_	_	B-Landmark_occasion
25	a	_	a	_	DT	0	_	_	_	_	_	_	_	I-Landmark_occasion
26	third	_	third	_	JJ	0	_	_	_	_	_	_	_	I-Landmark_occasion
27	stage	_	stage	_	NN	0	_	_	_	_	_	_	_	I-Landmark_occasion
28	in	_	in	_	IN	0	_	_	_	_	_	_	_	B-Focal_occasion
29	which	_	which	_	WDT	0	_	_	_	_	_	_	_	I-Focal_occasion
30	30	_	30	_	CD	0	_	_	_	_	_	_	_	I-Focal_occasion
31	single	_	single	_	JJ	0	_	_	_	_	_	_	_	I-Focal_occasion
32	nucleotide	_	UNK	_	NN	0	_	_	_	_	_	_	_	I-Focal_occasion
33	polymorphisms	_	UNK	_	NNS	0	_	_	_	_	_	_	_	I-Focal_occasion
34	(	_	(	_	:	0	_	_	_	_	_	_	_	I-Focal_occasion
35	snps	_	UNK	_	NNP	0	_	_	_	_	_	_	_	I-Focal_occasion
36	)	_	)	_	:	0	_	_	_	_	_	_	_	I-Focal_occasion
37	were	_	be	_	VBD	0	_	_	_	_	_	_	_	O
38	tested	_	test	_	VBN	0	_	_	_	_	_	_	_	O
39	for	_	for	_	IN	0	_	_	_	_	_	_	_	O
40	confirmation	_	confirmation	_	NN	0	_	_	_	_	_	_	_	O
41	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
42	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
43	cases	_	case	_	NNS	0	_	_	_	_	_	_	_	O
44	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
45	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
46	controls	_	control	_	NNS	0	_	_	_	_	_	_	_	O
47	from	_	from	_	IN	0	_	_	_	_	_	_	_	O
48	s22	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
49	studies	_	study	_	NNS	0	_	_	_	_	_	_	_	O
50	.	_	.	_	.	0	_	_	_	_	_	_	_	O

1	to	_	To	_	TO	0	_	_	_	_	_	_	_	O
2	identify	_	identify	_	VB	0	_	_	_	_	_	_	_	O
3	further	_	further	_	JJ	0	_	_	_	_	_	_	_	O
4	susceptibility	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
5	alleles	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O
6	,	_	,	_	,	0	_	_	_	_	_	_	_	O
7	we	_	we	_	PRP	0	_	_	_	_	_	_	_	O
8	conducted	_	conduct	_	VBD	0	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	0	_	_	_	_	_	_	_	O
10	two-stage	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
11	genome-wide	_	UNK	_	JJ	0	_	_	_	_	_	_	_	O
12	association	_	association	_	NN	0	_	_	_	_	_	_	_	O
13	study	_	study	_	NN	0	_	_	_	_	_	_	_	O
14	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
16	breast	_	breast	_	NN	0	_	_	_	_	_	_	_	O
17	cancer	_	cancer	_	NN	0	_	_	_	_	_	_	_	O
18	cases	_	case	_	NNS	0	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
21	controls	_	control	_	NNS	0	_	_	_	_	_	_	_	O
22	,	_	,	_	,	0	_	_	_	_	_	_	_	O
23	followed	_	follow	_	VBD	0	_	_	_	_	_	_	_	O
24	by	_	by	_	IN	0	_	_	_	_	_	_	_	O
25	a	_	a	_	DT	0	_	_	_	_	_	_	_	O
26	third	_	third	_	JJ	0	_	_	_	_	_	third.a	Ordinal_numbers	O
27	stage	_	stage	_	NN	0	_	_	_	_	_	_	_	S-Type
28	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
29	which	_	which	_	WDT	0	_	_	_	_	_	_	_	O
30	30	_	30	_	CD	0	_	_	_	_	_	_	_	O
31	single	_	single	_	JJ	0	_	_	_	_	_	_	_	O
32	nucleotide	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
33	polymorphisms	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O
34	(	_	(	_	:	0	_	_	_	_	_	_	_	O
35	snps	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
36	)	_	)	_	:	0	_	_	_	_	_	_	_	O
37	were	_	be	_	VBD	0	_	_	_	_	_	_	_	O
38	tested	_	test	_	VBN	0	_	_	_	_	_	_	_	O
39	for	_	for	_	IN	0	_	_	_	_	_	_	_	O
40	confirmation	_	confirmation	_	NN	0	_	_	_	_	_	_	_	O
41	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
42	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
43	cases	_	case	_	NNS	0	_	_	_	_	_	_	_	O
44	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
45	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
46	controls	_	control	_	NNS	0	_	_	_	_	_	_	_	O
47	from	_	from	_	IN	0	_	_	_	_	_	_	_	O
48	s22	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
49	studies	_	study	_	NNS	0	_	_	_	_	_	_	_	O
50	.	_	.	_	.	0	_	_	_	_	_	_	_	O

1	to	_	To	_	TO	0	_	_	_	_	_	_	_	O
2	identify	_	identify	_	VB	0	_	_	_	_	_	_	_	O
3	further	_	further	_	JJ	0	_	_	_	_	_	_	_	O
4	susceptibility	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
5	alleles	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O
6	,	_	,	_	,	0	_	_	_	_	_	_	_	O
7	we	_	we	_	PRP	0	_	_	_	_	_	_	_	O
8	conducted	_	conduct	_	VBD	0	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	0	_	_	_	_	_	_	_	O
10	two-stage	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
11	genome-wide	_	UNK	_	JJ	0	_	_	_	_	_	_	_	O
12	association	_	association	_	NN	0	_	_	_	_	_	_	_	O
13	study	_	study	_	NN	0	_	_	_	_	_	_	_	O
14	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
16	breast	_	breast	_	NN	0	_	_	_	_	_	_	_	O
17	cancer	_	cancer	_	NN	0	_	_	_	_	_	_	_	O
18	cases	_	case	_	NNS	0	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
21	controls	_	control	_	NNS	0	_	_	_	_	_	_	_	O
22	,	_	,	_	,	0	_	_	_	_	_	_	_	O
23	followed	_	follow	_	VBD	0	_	_	_	_	_	_	_	O
24	by	_	by	_	IN	0	_	_	_	_	_	_	_	O
25	a	_	a	_	DT	0	_	_	_	_	_	_	_	O
26	third	_	third	_	JJ	0	_	_	_	_	_	_	_	O
27	stage	_	stage	_	NN	0	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
29	which	_	which	_	WDT	0	_	_	_	_	_	_	_	O
30	30	_	30	_	CD	0	_	_	_	_	_	_	_	O
31	single	_	single	_	JJ	0	_	_	_	_	_	_	_	B-Product
32	nucleotide	_	UNK	_	NN	0	_	_	_	_	_	_	_	I-Product
33	polymorphisms	_	UNK	_	NNS	0	_	_	_	_	_	_	_	I-Product
34	(	_	(	_	:	0	_	_	_	_	_	_	_	I-Product
35	snps	_	UNK	_	NNP	0	_	_	_	_	_	_	_	I-Product
36	)	_	)	_	:	0	_	_	_	_	_	_	_	I-Product
37	were	_	be	_	VBD	0	_	_	_	_	_	_	_	O
38	tested	_	test	_	VBN	0	_	_	_	_	_	test.v	Operational_testing	O
39	for	_	for	_	IN	0	_	_	_	_	_	_	_	B-Product
40	confirmation	_	confirmation	_	NN	0	_	_	_	_	_	_	_	I-Product
41	in	_	in	_	IN	0	_	_	_	_	_	_	_	I-Product
42	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	I-Product
43	cases	_	case	_	NNS	0	_	_	_	_	_	_	_	I-Product
44	and	_	and	_	CC	0	_	_	_	_	_	_	_	I-Product
45	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	I-Product
46	controls	_	control	_	NNS	0	_	_	_	_	_	_	_	I-Product
47	from	_	from	_	IN	0	_	_	_	_	_	_	_	I-Product
48	s22	_	UNK	_	NNP	0	_	_	_	_	_	_	_	I-Product
49	studies	_	study	_	NNS	0	_	_	_	_	_	_	_	I-Product
50	.	_	.	_	.	0	_	_	_	_	_	_	_	O

1	to	_	To	_	TO	0	_	_	_	_	_	_	_	O
2	identify	_	identify	_	VB	0	_	_	_	_	_	_	_	O
3	further	_	further	_	JJ	0	_	_	_	_	_	_	_	O
4	susceptibility	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
5	alleles	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O
6	,	_	,	_	,	0	_	_	_	_	_	_	_	O
7	we	_	we	_	PRP	0	_	_	_	_	_	_	_	O
8	conducted	_	conduct	_	VBD	0	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	0	_	_	_	_	_	_	_	O
10	two-stage	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
11	genome-wide	_	UNK	_	JJ	0	_	_	_	_	_	_	_	O
12	association	_	association	_	NN	0	_	_	_	_	_	_	_	O
13	study	_	study	_	NN	0	_	_	_	_	_	_	_	O
14	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
16	breast	_	breast	_	NN	0	_	_	_	_	_	_	_	O
17	cancer	_	cancer	_	NN	0	_	_	_	_	_	_	_	O
18	cases	_	case	_	NNS	0	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
21	controls	_	control	_	NNS	0	_	_	_	_	_	_	_	O
22	,	_	,	_	,	0	_	_	_	_	_	_	_	O
23	followed	_	follow	_	VBD	0	_	_	_	_	_	_	_	O
24	by	_	by	_	IN	0	_	_	_	_	_	_	_	O
25	a	_	a	_	DT	0	_	_	_	_	_	_	_	O
26	third	_	third	_	JJ	0	_	_	_	_	_	_	_	O
27	stage	_	stage	_	NN	0	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
29	which	_	which	_	WDT	0	_	_	_	_	_	_	_	O
30	30	_	30	_	CD	0	_	_	_	_	_	_	_	O
31	single	_	single	_	JJ	0	_	_	_	_	_	_	_	O
32	nucleotide	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
33	polymorphisms	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O
34	(	_	(	_	:	0	_	_	_	_	_	_	_	O
35	snps	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
36	)	_	)	_	:	0	_	_	_	_	_	_	_	O
37	were	_	be	_	VBD	0	_	_	_	_	_	_	_	O
38	tested	_	test	_	VBN	0	_	_	_	_	_	_	_	O
39	for	_	for	_	IN	0	_	_	_	_	_	_	_	O
40	confirmation	_	confirmation	_	NN	0	_	_	_	_	_	confirmation.n	Verification	O
41	in	_	in	_	IN	0	_	_	_	_	_	_	_	B-Unconfirmed_content
42	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	I-Unconfirmed_content
43	cases	_	case	_	NNS	0	_	_	_	_	_	_	_	I-Unconfirmed_content
44	and	_	and	_	CC	0	_	_	_	_	_	_	_	I-Unconfirmed_content
45	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	I-Unconfirmed_content
46	controls	_	control	_	NNS	0	_	_	_	_	_	_	_	I-Unconfirmed_content
47	from	_	from	_	IN	0	_	_	_	_	_	_	_	I-Unconfirmed_content
48	s22	_	UNK	_	NNP	0	_	_	_	_	_	_	_	I-Unconfirmed_content
49	studies	_	study	_	NNS	0	_	_	_	_	_	_	_	I-Unconfirmed_content
50	.	_	.	_	.	0	_	_	_	_	_	_	_	O

1	to	_	To	_	TO	0	_	_	_	_	_	_	_	O
2	identify	_	identify	_	VB	0	_	_	_	_	_	_	_	O
3	further	_	further	_	JJ	0	_	_	_	_	_	_	_	O
4	susceptibility	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
5	alleles	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O
6	,	_	,	_	,	0	_	_	_	_	_	_	_	O
7	we	_	we	_	PRP	0	_	_	_	_	_	_	_	O
8	conducted	_	conduct	_	VBD	0	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	0	_	_	_	_	_	_	_	O
10	two-stage	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
11	genome-wide	_	UNK	_	JJ	0	_	_	_	_	_	_	_	O
12	association	_	association	_	NN	0	_	_	_	_	_	_	_	O
13	study	_	study	_	NN	0	_	_	_	_	_	_	_	O
14	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
16	breast	_	breast	_	NN	0	_	_	_	_	_	_	_	O
17	cancer	_	cancer	_	NN	0	_	_	_	_	_	_	_	O
18	cases	_	case	_	NNS	0	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
21	controls	_	control	_	NNS	0	_	_	_	_	_	_	_	O
22	,	_	,	_	,	0	_	_	_	_	_	_	_	O
23	followed	_	follow	_	VBD	0	_	_	_	_	_	_	_	O
24	by	_	by	_	IN	0	_	_	_	_	_	_	_	O
25	a	_	a	_	DT	0	_	_	_	_	_	_	_	O
26	third	_	third	_	JJ	0	_	_	_	_	_	_	_	O
27	stage	_	stage	_	NN	0	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
29	which	_	which	_	WDT	0	_	_	_	_	_	_	_	O
30	30	_	30	_	CD	0	_	_	_	_	_	_	_	O
31	single	_	single	_	JJ	0	_	_	_	_	_	_	_	O
32	nucleotide	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
33	polymorphisms	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O
34	(	_	(	_	:	0	_	_	_	_	_	_	_	O
35	snps	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
36	)	_	)	_	:	0	_	_	_	_	_	_	_	O
37	were	_	be	_	VBD	0	_	_	_	_	_	_	_	O
38	tested	_	test	_	VBN	0	_	_	_	_	_	_	_	O
39	for	_	for	_	IN	0	_	_	_	_	_	_	_	O
40	confirmation	_	confirmation	_	NN	0	_	_	_	_	_	_	_	O
41	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
42	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	S-Type
43	cases	_	case	_	NNS	0	_	_	_	_	_	case.n	Instance	S-Instance
44	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
45	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
46	controls	_	control	_	NNS	0	_	_	_	_	_	_	_	O
47	from	_	from	_	IN	0	_	_	_	_	_	_	_	O
48	s22	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
49	studies	_	study	_	NNS	0	_	_	_	_	_	_	_	O
50	.	_	.	_	.	0	_	_	_	_	_	_	_	O

1	to	_	To	_	TO	0	_	_	_	_	_	_	_	O
2	identify	_	identify	_	VB	0	_	_	_	_	_	_	_	O
3	further	_	further	_	JJ	0	_	_	_	_	_	_	_	O
4	susceptibility	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
5	alleles	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O
6	,	_	,	_	,	0	_	_	_	_	_	_	_	O
7	we	_	we	_	PRP	0	_	_	_	_	_	_	_	O
8	conducted	_	conduct	_	VBD	0	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	0	_	_	_	_	_	_	_	O
10	two-stage	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
11	genome-wide	_	UNK	_	JJ	0	_	_	_	_	_	_	_	O
12	association	_	association	_	NN	0	_	_	_	_	_	_	_	O
13	study	_	study	_	NN	0	_	_	_	_	_	_	_	O
14	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
16	breast	_	breast	_	NN	0	_	_	_	_	_	_	_	O
17	cancer	_	cancer	_	NN	0	_	_	_	_	_	_	_	O
18	cases	_	case	_	NNS	0	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
21	controls	_	control	_	NNS	0	_	_	_	_	_	_	_	O
22	,	_	,	_	,	0	_	_	_	_	_	_	_	O
23	followed	_	follow	_	VBD	0	_	_	_	_	_	_	_	O
24	by	_	by	_	IN	0	_	_	_	_	_	_	_	O
25	a	_	a	_	DT	0	_	_	_	_	_	_	_	O
26	third	_	third	_	JJ	0	_	_	_	_	_	_	_	O
27	stage	_	stage	_	NN	0	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
29	which	_	which	_	WDT	0	_	_	_	_	_	_	_	O
30	30	_	30	_	CD	0	_	_	_	_	_	_	_	O
31	single	_	single	_	JJ	0	_	_	_	_	_	_	_	O
32	nucleotide	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
33	polymorphisms	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O
34	(	_	(	_	:	0	_	_	_	_	_	_	_	O
35	snps	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
36	)	_	)	_	:	0	_	_	_	_	_	_	_	O
37	were	_	be	_	VBD	0	_	_	_	_	_	_	_	O
38	tested	_	test	_	VBN	0	_	_	_	_	_	_	_	O
39	for	_	for	_	IN	0	_	_	_	_	_	_	_	O
40	confirmation	_	confirmation	_	NN	0	_	_	_	_	_	_	_	O
41	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
42	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
43	cases	_	case	_	NNS	0	_	_	_	_	_	_	_	O
44	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
45	unk	_	UNK	_	CD	0	_	_	_	_	_	_	_	O
46	controls	_	control	_	NNS	0	_	_	_	_	_	_	_	O
47	from	_	from	_	IN	0	_	_	_	_	_	_	_	O
48	s22	_	UNK	_	NNP	0	_	_	_	_	_	_	_	S-Ground
49	studies	_	study	_	NNS	0	_	_	_	_	_	study.n	Scrutiny	O
50	.	_	.	_	.	0	_	_	_	_	_	_	_	O

